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Background: Patients not adherent to one drug class may be more likely to discontinue a newly prescribed therapy. We sought to determine if the 
level of adherence to antihypertensive medication prior to initiating statin therapy is associated with statin discontinuation.
methods: Using a 5% national random sample of Medicare beneficiaries enrolled in traditional fee-for-service Medicare with prescription drug 
coverage in 2007, we identified new users of statins defined by filling ≥1 statin prescription in 2007 without a statin prescription in the previous 
365 days (the “baseline” period). Statin discontinuation was defined as failure to renew statins within 1 year of initiating treatment with no 
subsequent fills for 365 days. Antihypertensive medication adherence was assessed by computing medication possession ratios (MPR) for diuretics, 
calcium channel blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors, and beta blockers at baseline.
results: Of 25,308 new statin users, 18,434 (72.8%) took antihypertensive drugs during the baseline period. Of beneficiaries taking 
antihypertensive medications, 61.2%, 25.8% and 13.0% had an MPR of ≥ 80%, 50% to <80% and < 50%, , respectively. Lower adherence to 
antihypertensive medications was associated with an increased hazard ratio for statin discontinuation. (Table)
conclusion: Low adherence to antihypertensive medication may be useful in identifying patients likely to discontinue statins within one year of 
initiation. 
Table: Proportion discontinuing within one year and hazard ratio for statin discontinuation associated with adherence to antihypertensive 
medications during baseline.
Medication Possession Ratio for antihypertensive drugs during baseline†
≥ 80% 50 to < 80% < 50%
New statin users 11,277 4,748 2,409
% discontinuing statins within 1 year 19.6% 23.5% 26.3%
Hazard ratio* (95% confidence interval) 1 (Ref) 1.21 (1.13 - 1.30) 1.38 (1.26 - 1.51)
*Adjusted for sociodemographics; comorbidities, comedications, and health service utilization during baseline; and myopathy, liver enzyme 
testing, creatine kinase testing and health service utilization during follow-up.
† Baseline is the one year prior to initiating statins.
